In recognition of the role of patent information access in the current health crisis, this event will feature IPOPHL's ongoing effort to provide COVID-19-related patent information reports free of charge for the use of the pharma industry, academe and the general public.

IPOPHL will detail how to use these reports in driving the development of COVID-19 related technologies and its other useful patent search services. Industry experts will also be joining to share their experiences with IPOPHL's patent search services and how these boosted their R&D.

Launched on July 28, 2021

10:00 am - 12:00 nn

Via Zoom and streamed Live via Facebook

REPORTS

Patent Information: DEXAMETHASONE

as of July 21, 2021

Download here

Patent Information: IVERMECTIN

as of July 30, 2021

Download here

Patent Information: MOLNUPIRAVIR

as of Aug. 6, 2021

Download here

Patent Information: RITONAVIR

as of Aug. 13, 2021

Download here

Patent Information: LOPINAVIR

as of Aug. 23, 2021

Download here

Patent Information: LOPINAVIR + RITONAVIR (LPV/r)

as of Aug. 26, 2021

Download here

Patent Information: FAVIPIRAVIR

as of Sept. 3, 2021

Download here

Patent Information:
METHYLPREDNISOLONE

as of Sept. 10, 2021

Download here

Patent Information: MELATONIN

as of Sept. 16, 2021

Download here

Patent Information: LAGUNDI

as of Sept. 27, 2021

Download here

Patent Information: CHLOROQUINE / HYDROXYCHLOROQUINE

as of Oct. 12, 2021

Download here

Patent Information: TOCILIZUMAB

as of Oct. 26, 2021

Download here

Patent Information: CASIRIVIMAB + IMDEVIMAB

as of Nov. 15, 2021

Download here

Patent Information: VCO

as of Jan. 10, 2022

Download here

Patent Information: REMDESIVIR

as of Jan. 25, 2022

Download here

Patent Information: OSELTAMIVIR PHOSPHATE

as of Feb. 8, 2022

Download here

Patent Information: IMATINIB

as of Feb. 25, 2022

Download here

Patent Information: INFLIXIMAB

as of Feb. 18, 2022

Download here

Patent Information: ARTESUNATE

as of April 19, 2022

Download here

Patent Information: BARICITINIB

as of April 5, 2022

Download here

Patent Information: IBRUTINIB

as of May 23, 2022

Download here

Patent Information: COLCHICINE

as of June 15, 2022

Download here